prednisone has been researched along with Melanoma in 71 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we report a case of a 75-year-old man with myasthenia gravis and metastatic melanoma who experienced complete and durable systemic regression after receiving pembrolizumab and single-lesion RT while on prednisone for myasthenia gravis prophylaxis and vedolizumab for immune-mediated colitis after previously experiencing mixed response on pembrolizumab monotherapy." | 5.12 | Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated Colitis. ( Clark, CA; Deshane, AS; Dobelbower, MC; Moradi, LA; Schneider, CS, 2021) |
| "We describe two cases of CIDP secondary to treatment with combined ipilimumab and nivolumab in patients with metastatic melanoma that were successfully treated with prednisone and IVIG." | 3.91 | Chronic inflammatory demyelinating polyradiculoneuropathy secondary to immune checkpoint inhibitors in melanoma patients. ( Patel, AS; Sehdev, A; Snook, RJ, 2019) |
| " ICIs initate antitumor immunity; however, these agents are associated with immune-related adverse events (irAEs) that may affect a variety of organs." | 2.61 | Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review. ( Reynolds, KL; Seethapathy, H; Sise, ME, 2019) |
| "ICIs can cause rheumatic adverse events, resulting in decreased quality of life that may require immunesuppressive treatment." | 1.91 | [Rheumatic adverse events due to immune checkpoint inhibitors]. ( Heslinga, SC; Labots, M; Lems, WF; Tsang-A-Sjoe, MWP; van Binsbergen, WH; van der Laken, J, 2023) |
| "Eosinophilia has been reported as a rare, new biological effect of immune checkpoint inhibition that may be associated with improved treatment response and the development of immune-related adverse events." | 1.51 | Dual checkpoint inhibitor-associated eosinophilic enteritis. ( Carvajal, RD; Lagana, SM; Saenger, YM; Yang, J, 2019) |
| "Colitis was defined by diarrhea (grade≥2) requiring steroids with or without endoscopic/histologic/radiologic evidence of colitis." | 1.42 | Ipilimumab-induced colitis in patients with metastatic melanoma. ( De Felice, KM; Finnes, HD; Gupta, A; Khanna, S; Kottschade, LA; Loftus, EV; Markovic, SN; Papadakis, KA; Raffals, LE; Rakshit, S, 2015) |
| "Eosinophilic fasciitis (EF) is a rare inflammatory and fibrosing disorder with clinical, biological and histological characteristics." | 1.35 | [Eosinophilic fasciitis and metastatic choroïdal melanoma: a paraneoplastic syndrome?]. ( Dendale, R; Lumbroso-Le Rouic, L; Récanati, G; Veyssier-Belot, C; Zuech, P, 2008) |
| "We report a case of disseminated superficial actinic porokeratosis (DSAP) with neutrophilic pustules within cornoid lamellae on histopathologic examination, corresponding to pustules along the elevated rim clinically as well." | 1.35 | Pustular porokeratosis. ( Miller, DD; Ruben, BS, 2009) |
| "Opsoclonus-myoclonus is a well-described paraneoplastic syndrome that most often occurs in association with small cell carcinoma of the lung and breast carcinoma." | 1.30 | Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma. ( Berger, JR; Mehari, E, 1999) |
| "Leukocytosis has been noted in association with many non-hematologic malignancies in the absence of concurrent infection or metastatic involvement of bone marrow." | 1.27 | Leukocytosis due to adrenal metastases from malignant melanoma: reversal after bilateral adrenalectomy with long-term survival. ( Carey, RW; Kunz, VS, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (25.35) | 18.7374 |
| 1990's | 7 (9.86) | 18.2507 |
| 2000's | 8 (11.27) | 29.6817 |
| 2010's | 29 (40.85) | 24.3611 |
| 2020's | 9 (12.68) | 2.80 |
| Authors | Studies |
|---|---|
| Moradi, LA | 1 |
| Clark, CA | 1 |
| Schneider, CS | 1 |
| Deshane, AS | 1 |
| Dobelbower, MC | 1 |
| Habibi, S | 1 |
| Soliman, A | 1 |
| Dasanu, CA | 1 |
| van Binsbergen, WH | 1 |
| Heslinga, SC | 1 |
| Lems, WF | 1 |
| Tsang-A-Sjoe, MWP | 1 |
| Labots, M | 1 |
| van der Laken, J | 1 |
| Yang, J | 1 |
| Lagana, SM | 1 |
| Saenger, YM | 1 |
| Carvajal, RD | 1 |
| Navarro-Perea, C | 1 |
| Garcia-Gonzalez, J | 1 |
| Perez-Blazquez, E | 1 |
| Patel, AS | 1 |
| Snook, RJ | 1 |
| Sehdev, A | 1 |
| Taillefer, VT | 1 |
| Pigeon, M | 1 |
| Chen, M | 2 |
| Larochelle, C | 1 |
| Florescu, M | 1 |
| Bélanger, K | 1 |
| Adam, JP | 1 |
| Yaşar, HA | 1 |
| Akkus, E | 1 |
| Heper, A | 1 |
| Akay, BN | 1 |
| Urun, Y | 1 |
| Utkan, G | 1 |
| Calvani, J | 1 |
| Elia, R | 1 |
| Battistella, M | 1 |
| Delyon, J | 1 |
| Vivier-Chicoteau, J | 1 |
| Gornet, JM | 1 |
| Lebbé, C | 1 |
| Baroudjian, B | 1 |
| Bertheau, P | 1 |
| Liu, H | 1 |
| Kuang, X | 1 |
| Zhang, Y | 1 |
| Ye, Y | 1 |
| Li, J | 1 |
| Liang, L | 1 |
| Xie, Z | 1 |
| Weng, L | 1 |
| Guo, J | 1 |
| Li, H | 1 |
| Ma, F | 1 |
| Chen, X | 2 |
| Zhao, S | 1 |
| Su, J | 1 |
| Yang, N | 1 |
| Fang, F | 1 |
| Xie, Y | 1 |
| Tao, J | 1 |
| Zhang, J | 1 |
| Peng, C | 1 |
| Sun, L | 1 |
| Zhang, X | 1 |
| Liu, J | 1 |
| Han, L | 1 |
| Xu, X | 1 |
| Hung, MC | 1 |
| Morris, LM | 1 |
| Lewis, HA | 1 |
| Cornelius, LA | 1 |
| Chen, DY | 1 |
| Rosman, IS | 1 |
| Okoye, IS | 1 |
| Xu, L | 1 |
| Walker, J | 1 |
| Elahi, S | 1 |
| Jain, A | 1 |
| Lipson, EJ | 2 |
| Sharfman, WH | 2 |
| Brant, SR | 1 |
| Lazarev, MG | 1 |
| Kanno, H | 1 |
| Ishida, K | 1 |
| Yamada, W | 1 |
| Nishida, T | 1 |
| Takahashi, N | 1 |
| Mochizuki, K | 1 |
| Mizuno, Y | 1 |
| Matsuyama, K | 1 |
| Takahashi, T | 1 |
| Seishima, M | 1 |
| Maeda, T | 1 |
| Yanagi, T | 1 |
| Imafuku, K | 1 |
| Kitamura, S | 1 |
| Hata, H | 1 |
| Izumi, K | 1 |
| Ujiie, H | 1 |
| Iwata, H | 1 |
| Shimizu, H | 1 |
| Sun, Y | 1 |
| Lee, SK | 1 |
| Oo, TH | 1 |
| Rojas-Hernandez, CM | 1 |
| Amber, KT | 1 |
| Valdebran, M | 1 |
| Lu, Y | 1 |
| De Feraudy, S | 1 |
| Linden, KG | 1 |
| Ngo, L | 1 |
| Miller, E | 1 |
| Valen, P | 1 |
| Gertner, E | 1 |
| Amini-Adle, M | 1 |
| Piperno, M | 1 |
| Tordo, J | 1 |
| Thomas, L | 1 |
| Dalle, S | 1 |
| Dubois, V | 1 |
| Marabelle, A | 1 |
| Arays, R | 1 |
| Wang, P | 1 |
| Sadaat, M | 1 |
| Jang, S | 1 |
| Jespersen, H | 1 |
| Bjursten, S | 1 |
| Ny, L | 1 |
| Levin, M | 1 |
| Boiché, M | 1 |
| Conart, JB | 1 |
| Angioi-Duprez, K | 1 |
| Cheng, MW | 1 |
| Hisaw, LD | 1 |
| Bernet, L | 1 |
| Rao, BB | 1 |
| Robertson, S | 1 |
| Philpott, J | 1 |
| Sise, ME | 1 |
| Seethapathy, H | 1 |
| Reynolds, KL | 1 |
| Klein, O | 1 |
| Ribas, A | 1 |
| Chmielowski, B | 1 |
| Walker, G | 1 |
| Clements, A | 2 |
| Long, GV | 1 |
| Kefford, RF | 1 |
| Anderson, L | 1 |
| Bhatia, V | 1 |
| Bodell, MA | 1 |
| Kraus, ES | 1 |
| Kyllo, RL | 1 |
| Parker, MK | 1 |
| Rosman, I | 1 |
| Musiek, AC | 1 |
| Fonollosa, A | 1 |
| Mesquida, M | 1 |
| Adan, A | 1 |
| Carlos, G | 1 |
| Anforth, R | 1 |
| Chou, S | 1 |
| Fernandez-Peñas, P | 1 |
| De Felice, KM | 1 |
| Gupta, A | 1 |
| Rakshit, S | 1 |
| Khanna, S | 1 |
| Kottschade, LA | 1 |
| Finnes, HD | 1 |
| Papadakis, KA | 1 |
| Loftus, EV | 1 |
| Raffals, LE | 1 |
| Markovic, SN | 1 |
| Klair, JS | 1 |
| Girotra, M | 1 |
| Hutchins, LF | 1 |
| Caradine, KD | 1 |
| Aduli, F | 1 |
| Garcia-Saenz-de-Sicilia, M | 1 |
| Veyssier-Belot, C | 1 |
| Zuech, P | 1 |
| Lumbroso-Le Rouic, L | 1 |
| Récanati, G | 1 |
| Dendale, R | 1 |
| Miller, DD | 1 |
| Ruben, BS | 1 |
| Balachandran, I | 1 |
| Walker, JW | 1 |
| Broman, J | 1 |
| Yu, GH | 1 |
| Qu, GM | 1 |
| Yao, WD | 1 |
| Lang, ZQ | 1 |
| Wang, W | 1 |
| Fontanilla, FA | 1 |
| Edward, DP | 1 |
| Wong, M | 1 |
| Tessler, HH | 1 |
| Eagle, RC | 1 |
| Goldstein, DA | 1 |
| Xu, XF | 1 |
| Zhang, XJ | 1 |
| Schoenberger, SD | 1 |
| Kim, SJ | 1 |
| Lavin, P | 1 |
| Li, XX | 1 |
| Sang, W | 1 |
| Zhang, W | 1 |
| Shi, XL | 1 |
| Gulinaer, A | 1 |
| Yang, WT | 1 |
| KAUFMAN, HE | 1 |
| Liu, JK | 1 |
| Kan, P | 1 |
| Schmidt, MH | 1 |
| Siegelmann-Danieli, N | 1 |
| Bardo, M | 1 |
| Law, A | 1 |
| Fisk, D | 1 |
| Bernath, A | 1 |
| Wendling, D | 1 |
| Aubin, F | 1 |
| McQuillen, MP | 1 |
| Norrell, H | 1 |
| Czarnetzki, BM | 1 |
| Macher, E | 1 |
| Cuchural, GJ | 1 |
| Levey, AS | 1 |
| Pauker, SG | 1 |
| Kaufmann, B | 1 |
| Wegmann, W | 1 |
| Lanza, L | 1 |
| Peirano, L | 1 |
| Bosco, O | 1 |
| Contini, P | 1 |
| Filaci, G | 1 |
| Setti, M | 1 |
| Puppo, F | 1 |
| Indiveri, F | 1 |
| Scudeletti, M | 1 |
| Tucker, SM | 1 |
| Hurwitz, JJ | 1 |
| Pavlin, CJ | 1 |
| Howarth, DJ | 1 |
| Nianiaris, N | 1 |
| Falk, S | 1 |
| Walther, F | 1 |
| Denk, R | 1 |
| Szepietowski, J | 1 |
| Wasik, F | 1 |
| Szepietowski, T | 1 |
| Włodarczyk, M | 1 |
| Sobczak-Radwan, K | 1 |
| Czyz, W | 1 |
| Gündüz, K | 1 |
| Shields, CL | 1 |
| Shields, JA | 1 |
| Schubert, H | 1 |
| Berger, JR | 1 |
| Mehari, E | 1 |
| Creager, AJ | 1 |
| Geisinger, KR | 1 |
| Bergman, S | 1 |
| Mérot, Y | 1 |
| Miescher, PA | 1 |
| Balsiger, F | 1 |
| Magnenat, P | 1 |
| Frenk, E | 1 |
| Borden, EC | 1 |
| Hawkins, MJ | 1 |
| Eisner, SB | 1 |
| Mitnick, PD | 1 |
| Carey, RW | 1 |
| Kunz, VS | 1 |
| Tashima, CK | 1 |
| Jaffe, N | 1 |
| Traggis, D | 1 |
| Das, L | 1 |
| Moloney, WC | 1 |
| Hann, HW | 1 |
| Kim, BS | 1 |
| Nair, R | 1 |
| Mathé, G | 1 |
| Amiel, JL | 1 |
| Clarysse, A | 1 |
| Hayat, M | 1 |
| Schwarzenberg, L | 1 |
| Carter, SK | 1 |
| Gutterman, JU | 1 |
| Mavligit, GM | 1 |
| Reed, RC | 1 |
| Hersh, EM | 1 |
| Manny, N | 1 |
| Rosenman, E | 1 |
| Benbassat, J | 1 |
| Gottlieb, JA | 1 |
| Frei, E | 1 |
| Luce, JK | 1 |
| Birge, HL | 1 |
| Gilbert, TT | 1 |
| Evjy, JT | 1 |
| Edelstein, L | 1 |
| Ryan, SJ | 1 |
| Frank, RN | 1 |
| Green, WR | 1 |
9 reviews available for prednisone and Melanoma
| Article | Year |
|---|---|
Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated Colitis.
Topics: Aged; Antibodies, Monoclonal, Humanized; Chemoradiotherapy; Colitis; Humans; Immune Checkpoint Inhib | 2021 |
Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Humans; Immunotherapy; Lymp | 2018 |
Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Antineoplastic Agents, Immunological; Disease Managem | 2019 |
Ipilimumab-associated Sweet syndrome in a patient with high-risk melanoma.
Topics: Aged; Antibodies, Monoclonal; Biopsy, Needle; Chemotherapy, Adjuvant; Dapsone; Female; Follow-Up Stu | 2014 |
THE UVEA.
Topics: Anatomy; Arthritis; Autoantibodies; Betamethasone; Dexamethasone; Dihydroxyphenylalanine; Epidemiolo | 1964 |
[Metastatic malignant melanoma in treated non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Humans; Lymph Nodes; Lymphatic | 1996 |
Biologic response modifiers as adjuncts to other therapeutic modalities.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast | 1986 |
An overview of the status of the nitrosoureas in other tumors.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Br | 1973 |
Immunochemotherapy of human cancer.
Topics: Acute Disease; Adjuvants, Immunologic; Adult; Animals; Antineoplastic Agents; BCG Vaccine; Cytarabin | 1974 |
1 trial available for prednisone and Melanoma
| Article | Year |
|---|---|
Biologic response modifiers as adjuncts to other therapeutic modalities.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast | 1986 |
62 other studies available for prednisone and Melanoma
| Article | Year |
|---|---|
Cycle-dependent eosinophilia due to adjuvant nivolumab for malignant melanoma.
Topics: Aged; Antineoplastic Agents, Immunological; Eosinophilia; Humans; Male; Melanoma; Melanoma, Cutaneou | 2023 |
[Rheumatic adverse events due to immune checkpoint inhibitors].
Topics: Aged; Arthritis; Female; Humans; Immune Checkpoint Inhibitors; Male; Melanoma; Middle Aged; Nivoluma | 2023 |
Dual checkpoint inhibitor-associated eosinophilic enteritis.
Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Enteriti | 2019 |
Case report: Bilateral uveitis and papillitis secondary to treatment with pembrolizumab.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Drug Combinations; D | 2019 |
Chronic inflammatory demyelinating polyradiculoneuropathy secondary to immune checkpoint inhibitors in melanoma patients.
Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Female; | 2019 |
Very high-dose methylprednisolone for treatment of nivolumab-induced limbic encephalitis: A case report.
Topics: Aged; Autoimmune Diseases; Humans; Limbic Encephalitis; Male; Melanoma; Methylprednisolone; Nivoluma | 2020 |
Sweet's syndrome under ipilimumab therapy and a brief comparison of the cases in literature.
Topics: Biopsy; CTLA-4 Antigen; Female; Humans; Ipilimumab; Melanoma; Middle Aged; Prednisone; Skin Neoplasm | 2020 |
[An unusual digestive complication under anti-PD-1 (pembrolizumab)].
Topics: Aged; Antibodies, Monoclonal, Humanized; Budesonide; Colitis, Collagenous; Diarrhea; Humans; Hypokal | 2020 |
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis.
Topics: Activating Transcription Factor 3; Adenosine A1 Receptor Antagonists; Adult; Aged; Animals; Antineop | 2020 |
Neutrophil-predominant bullous pemphigoid induced by checkpoint inhibitors: A case series.
Topics: Aged; Antimalarials; Dapsone; Drug Eruptions; Drug Therapy, Combination; Glucocorticoids; Humans; Im | 2020 |
The glucocorticoids prednisone and dexamethasone differentially modulate T cell function in response to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; CTLA-4 Antigen; Dexamethason | 2020 |
Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis.
Topics: Administration, Intravenous; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antineoplastic Agents; | 2017 |
Uveitis induced by programmed cell death protein 1 inhibitor therapy with nivolumab in metastatic melanoma patient.
Topics: Administration, Ophthalmic; Antibodies, Monoclonal; Antineoplastic Agents; Betamethasone; Female; Gl | 2017 |
Using immune checkpoint inhibitors without exacerbation in a melanoma patient with pemphigus foliaceus.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Immunological; Fatal Outcome; Female; Humans; | 2017 |
Management of Immune-mediated Cytopenias in the Era of Cancer Immunotherapy: A Report of 4 Cases.
Topics: Anemia, Hemolytic; Antibodies, Monoclonal, Humanized; CTLA-4 Antigen; Drug-Related Side Effects and | 2018 |
Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma.
Topics: Administration, Oral; Administration, Topical; Aged, 80 and over; Antibodies, Monoclonal, Humanized; | 2018 |
Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Edema; Glucocorticoids; H | 2018 |
Remitting Seronegative Symmetric Synovitis With Pitting Edema Associated With Partial Melanoma Response Under Anti-CTLA-4 and Anti-Programmed Death 1 Combination Treatment.
Topics: Aged; Antineoplastic Agents, Immunological; CTLA-4 Antigen; Edema; Glucocorticoids; Humans; Ipilimum | 2018 |
A case of pembrolizumab-induced localized organizing pneumonia.
Topics: Antibodies, Monoclonal, Humanized; Brain; Cryptogenic Organizing Pneumonia; Drug-Related Side Effect | 2018 |
Checkpoint inhibitor-induced sarcoid reaction mimicking bone metastases.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Bone Neoplasms; Diagnosis, | 2018 |
[Severe panuveitis in a metastatic cutaneous melanoma patient treated with vemurafenib].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Female; Huma | 2018 |
Generalized morphea in the setting of pembrolizumab.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Biopsy; Choroid Neoplasms; | 2019 |
Checkpoint Inhibitor-Induced Hemorrhagic Gastritis with Pembrolizumab.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunolog | 2019 |
Facial palsy as a side effect of vemurafenib treatment in patients with metastatic melanoma.
Topics: Antineoplastic Agents, Hormonal; Facial Paralysis; Humans; Indoles; Male; Melanoma; Middle Aged; Pre | 2013 |
Ipilimumab immune-related adverse reactions: a case report.
Topics: Antibodies, Monoclonal; Autoimmune Diseases; Female; Follow-Up Studies; Humans; Hydrocortisone; Hypo | 2013 |
Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Dacarbazine; Drug Adminis | 2014 |
Uveitic macular oedema after treatment with vemurafenib.
Topics: Adult; Aged; Antineoplastic Agents; Dexamethasone; Drug Implants; Glucocorticoids; Humans; Indoles; | 2015 |
A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Dexamethas | 2015 |
Ipilimumab-induced colitis in patients with metastatic melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Budesonide; Colitis; | 2015 |
Ipilimumab-Induced Gastrointestinal Toxicities: A Management Algorithm.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis; Female; Gastrointestin | 2016 |
[Eosinophilic fasciitis and metastatic choroïdal melanoma: a paraneoplastic syndrome?].
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Inflammatory Agents; An | 2008 |
Pustular porokeratosis.
Topics: Antimetabolites, Antineoplastic; Azathioprine; Colitis, Ulcerative; Diabetes Mellitus, Type 2; Human | 2009 |
Fine needle aspiration cytology of ALK1(-), CD30+ anaplastic large cell lymphoma post renal transplantation: a case report and literature review.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor | 2010 |
[Intravascular large B-cell lymphoma: report of a case].
Topics: Antigens, CD20; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Di | 2009 |
Juvenile xanthogranuloma masquerading as melanoma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Child; Chlorambucil; Cyclosporine; Diag | 2009 |
[Extranodal follicular dendritic cell sarcoma of neck region: report of a case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyclophosphamide; Dendritic Cell Sarcoma, | 2012 |
Paraneoplastic optic neuropathy from cutaneous melanoma detected by positron emission tomographic and computed tomographic scanning.
Topics: Aged; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Lymph Node Excision; Lymph | 2012 |
[Clinicopathologic study of 20 cases of anaplastic large-cell lymphoma].
Topics: Adolescent; Adult; Aged; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; | 2012 |
Diffuse large B-cell lymphoma presenting as a sacral tumor. Report of two cases.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2003 |
Interstitial pneumonitis in a patient with melanoma treated with the high dose interferon alpha 2b regimen.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Female; Humans; Interferon alpha-2; Interferon-alph | 2004 |
Metastatic malignant melanoma in a patient taking interleukin-1 receptor antagonist.
Topics: Aged; Antimalarials; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Interleukin 1 Recepto | 2006 |
Late-onset myopathy and melanotic malignant melanoma.
Topics: Brain Neoplasms; Dexamethasone; Humans; Male; Melanoma; Middle Aged; Muscular Diseases; Myography; P | 1967 |
DTIC (dacarbazine)-induced hepatic damage. Possible pathogenesis and prevention.
Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Chemical and Drug Ind | 1981 |
Kidney failure or cancer. Should immunosuppression be continued in a transplant patient with malignant melanoma?
Topics: Adult; Azathioprine; Disease Susceptibility; Female; Glomerulonephritis; Graft Rejection; Humans; Im | 1984 |
[Bladder cancer and malignant melanoma following Endoxan therapy of a lymphoproliferative disease].
Topics: Adenoma; Carcinoma, Squamous Cell; Cervix Uteri; Cyclophosphamide; Drug Therapy, Combination; Female | 1981 |
Interferons up-regulate with different potency HLA class I antigen expression in M14 human melanoma cell line. Possible interaction with glucocorticoid hormones.
Topics: Drug Synergism; Gene Expression; Glucocorticoids; Histocompatibility Antigens Class I; Humans; In Vi | 1995 |
Scleral melt after cryotherapy for conjunctival melanoma.
Topics: Aged; Conjunctival Neoplasms; Cryosurgery; Humans; Male; Melanoma; Melanosis; Postoperative Complica | 1993 |
Excess benign melanocytic naevi in renal transplant recipients.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Back; Buttocks; Case-Control Studies; Cyclosporine; F | 1997 |
Presumed choroidal granuloma with vitreous hemorrhage resembling choroidal melanoma.
Topics: Administration, Oral; Adult; Choroid Diseases; Choroid Neoplasms; Diagnosis, Differential; Fluoresce | 1998 |
Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma.
Topics: Adult; Anti-Inflammatory Agents; Humans; Magnetic Resonance Imaging; Male; Melanoma; Myoclonus; Ocul | 1999 |
Neutrophil-rich Ki-1-positive anaplastic large cell lymphoma: a study by fine-needle aspiration biopsy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma; Cyclophosphamide; | 2002 |
Cutaneous malignant melanomas occurring under cyclosporin A therapy: a report of two cases.
Topics: Adult; Cyclosporins; Drug Therapy, Combination; Female; Humans; Kidney Transplantation; Male; Melano | 1990 |
Hypercalcemia and reversible renal failure in heavy-chain disease.
Topics: Acute Kidney Injury; Aged; Calcium; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combina | 1986 |
Leukocytosis due to adrenal metastases from malignant melanoma: reversal after bilateral adrenalectomy with long-term survival.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Combined Modality Therapy; Fludrocortisone; Humans; L | 1988 |
Association of malignant melanoma and malignant lymphoma.
Topics: Biopsy; Cyclophosphamide; Lymphatic Metastasis; Lymphoma; Melanoma; Neoplasm Metastasis; Neoplasm Re | 1973 |
L-asparaginase in the treatment of neoplastic diseases in children.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow Examination; Bone Neoplasms; Burkitt Ly | 1971 |
The place of the L-asparaginase in the treatment of acute leukemias.
Topics: Acute Disease; Adolescent; Adult; Animals; Asparaginase; Child; Child, Preschool; Chronic Disease; D | 1970 |
Hazard of immunosuppressive therapy.
Topics: Adult; Azathioprine; Female; Humans; Lupus Erythematosus, Systemic; Melanoma; Prednisone | 1972 |
An evaluation of the management of patients with cerebral metastases from malignant melanoma.
Topics: Adult; Aged; Amides; Brain; Brain Neoplasms; Coma; Dexamethasone; Evaluation Studies as Topic; Femal | 1972 |
An unusual malignant melanoma of the choroid affected by prednisone.
Topics: Choroid Neoplasms; Female; Humans; Melanoma; Middle Aged; Prednisone | 1970 |
Hodgkin's disease associated with Kaposi's sarcoma and malignant melanoma. Case report of multiple primary malignancies.
Topics: Aged; Arm; Fingers; Foot; Hand; Hodgkin Disease; Humans; Intestinal Neoplasms; Jejunum; Male; Melano | 1971 |
Bilateral inflammatory pseudotumors of the ciliary body.
Topics: Administration, Topical; Anti-Inflammatory Agents; Atropine; Biopsy; Ciliary Body; Diagnosis, Differ | 1971 |